
Hexavalent Vaccine Could Cut Costs, Ease Workload in India’s Immunisation Programme
The story in brief
A study in Human Vaccines & Immunotherapeutics says the hexavalent vaccine, combining six diseases into one shot, could improve India’s immunisation programme by reducing injections, easing healthcare worker workload, and lowering cold-chain needs. The vaccine’s price is the main cost factor, but a 50% cut could offset extra costs. Nearly 26 million Indian babies are vaccinated annually under the Universal Immunisation Programme.